Corcept Therapeutics, Inc. (CORT)
123.20
+0.95
(+0.78%)
USD |
NASDAQ |
Aug 24, 16:00
123.20
0.00 (0.00%)
After-Hours: 19:56
Corcept Therapeutics Shareholders Equity (Quarterly) : 705.78M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 705.78M |
| March 31, 2026 | 637.99M |
| December 31, 2025 | 647.80M |
| September 30, 2025 | 631.90M |
| June 30, 2025 | 635.79M |
| March 31, 2025 | 683.28M |
| December 31, 2024 | 679.59M |
| September 30, 2024 | 638.84M |
| June 30, 2024 | 596.24M |
| March 31, 2024 | 547.86M |
| December 31, 2023 | 506.70M |
| September 30, 2023 | 461.68M |
| June 30, 2023 | 421.61M |
| March 31, 2023 | 529.58M |
| December 31, 2022 | 501.84M |
| September 30, 2022 | 473.36M |
| June 30, 2022 | 442.33M |
| March 31, 2022 | 407.81M |
| December 31, 2021 | 375.81M |
| September 30, 2021 | 540.23M |
| June 30, 2021 | 522.68M |
| March 31, 2021 | 510.80M |
| December 31, 2020 | 523.34M |
| September 30, 2020 | 489.68M |
| June 30, 2020 | 453.70M |
| Date | Value |
|---|---|
| March 31, 2020 | 409.49M |
| December 31, 2019 | 371.18M |
| September 30, 2019 | 334.38M |
| June 30, 2019 | 298.05M |
| March 31, 2019 | 285.76M |
| December 31, 2018 | 275.88M |
| September 30, 2018 | 259.54M |
| June 30, 2018 | 243.51M |
| March 31, 2018 | 215.23M |
| December 31, 2017 | 190.97M |
| September 30, 2017 | 86.30M |
| June 30, 2017 | 66.14M |
| March 31, 2017 | 49.58M |
| December 31, 2016 | 41.38M |
| September 30, 2016 | 31.25M |
| June 30, 2016 | 25.66M |
| March 31, 2016 | 20.17M |
| December 31, 2015 | 18.50M |
| September 30, 2015 | 13.48M |
| June 30, 2015 | 11.53M |
| March 31, 2015 | 10.57M |
| December 31, 2014 | -3.388M |
| September 30, 2014 | -1.317M |
| June 30, 2014 | 3.452M |
| March 31, 2014 | 9.371M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abeona Therapeutics, Inc. | 128.06M |
| Liquidia Corp. | 195.11M |
| Indivior Pharmaceuticals, Inc. | -208.00M |
| Crinetics Pharmaceuticals, Inc. | 1.192B |
| Forum Markets, Inc. | 127.80M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 888.70M |
| Total Liabilities (Quarterly) | 182.93M |
| Debt to Equity Ratio | 0.0133 |
| Current Ratio | 2.830 |
| Net Debt Paydown Yield | -0.01% |